Abstract:
Methods, biomarkers, and expression signatures are disclosed for assessing the disease progression of Alzheimer's disease (AD). In one embodiment, BioAge (biological age), NdStress (neurodegenerative stress), Alz (Alzheimer), and Inflame (inflammation) are used as biomarkers of AD progression. In another aspect, the invention comprises a gene signature for evaluating disease progression. In still another embodiment, methods for evaluating disease progression are provided. In yet another embodiment, the invention can be used to identify animal models for use in the development and evaluation of therapeutics for the treatment of AD.
Abstract:
Certain types of wall-mount boxes provide a local power receptacle in a first interior region that is physically isolated from a second interior region. The local power receptacle is accessible from an exterior of the box. The local power receptacle is electrically connected to an internal connector interface that is accessible from the second interior region. An electronic device may be installed in the second interior region and electrically connected to the local power receptacle via the internal connector interface. Second receptacles are disposed in the second interior region and coupled to (or are integral with) the electronic device. The second receptacles are accessible from the exterior of the box.
Abstract:
A fiber panel system includes a chassis including a backplane; and at least a first blade configured to mount to the chassis. The first blade is moveable relative t the chassis between a retracted (closed) position and at least one extended position. The first blade includes a coupler arrangement for connecting together media segments. Each blade includes a blade processor and a plurality of smart couplers. A chassis processor is electrically coupled to a processor port of the chassis backplane.
Abstract:
One exemplary embodiment is directed to an inter-networking device that performs at least one inter-networking function using physical layer information about the network of which the device is a part. Another exemplary embodiment is directed to capturing physical layer information about physical communication media that is attached to an inter-networking device. Another exemplary embodiment is directed to a technique for generating a spanning tree and/or forwarding database information for a plurality of switches in a network at a central location. The spanning tree and/or forwarding database information is generated at the central location using information including physical layer information about devices and physical communication media in the network. Another exemplary embodiment is directed to an ETHERNET physical layer device having integrated support for capturing physical layer information about the physical communication media connected to the ETHERNET physical layer device.
Abstract:
Methods and systems herein provide for flexible formatting of print jobs and their associated logical pages. One N-up printing system is adapted to receive a print job from a host system for printing to a tangible medium. The print job includes at least a first logical page. The printing system includes an N-up formatter interface adapted to receive formatting parameters. The printing system also includes an N-up formatter that is communicatively coupled to the N-up formatter interface. The N-up formatter is adapted to generate a first page inclusion object based on the formatting parameters. The N-up formatter is further adapted to input the first logical page to the first page inclusion object and position the first logical page within the first page inclusion object.
Abstract:
The present invention provides methods modified oligonucleotides and methods of using the modified oligonucleotides for silencing nucleic acids, wherein the nonspecific effects of nucleic acid silencing are reduced.
Abstract:
Methods for identifying modulators of LRRTM1, LRRTM2 and LRRTM4 are described. The methods are particularly useful for identifying analytes that stimulate LRRTM1or LRRTM2 activity or inhibit LRRTM4 activity such that they antagonize processing of amyloid precursor protein (APP) to Aβ peptide (Aβ). Such methods can be used to identify analyties for treating Alzheimer disease.
Abstract:
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
Abstract:
An optically variable magnetic stripe assembly includes a magnetic layer (5), an optically variable effect generating layer (1, 2) over the magnetic layer (5), and, an electrically non-conductive reflective layer (12) between the magnetic layer (5) and the optically variable effect generating layer (1).
Abstract:
Methods for identifying modulators of KEAH6 are described. The methods are particularly useful for identifying analytes that antagonize KEAH6's effect on processing of amyloid precursor protein to Aβ peptide and thus useful for identifying analytes that can be used for treating Alzheimer disease.